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Abstract: Double-strand breaks (DSB) are one of the most lethal forms of DNA damage that, if left
unrepaired, can lead to genomic instability, cellular transformation, and cell death. In this work, we
examined how repair of transcription activator-like effector nuclease (TALEN)-induced DNA damage
was altered when knocking out, or inhibiting a function of, two DNA repair proteins, XRCC4 and
MRE11, respectively. We developed a fluorescent reporter assay that uses TALENs to introduce DSB
and detected repair by the presence of GFP fluorescence. We observed repair of TALEN-induced breaks
in the XRCC4 knockout cells treated with mirin (a pharmacological inhibitor of MRE11 exonuclease
activity), albeit with ~40% reduced efficiency compared to normal cells. Editing in the absence of XRCC4
or MRE11 exonuclease was robust, with little difference between the indel profiles amongst any of the
groups. Reviewing the transcriptional profiles of the mirin-treated XRCC4 knockout cells showed 307
uniquely differentially expressed genes, a number far greater than for either of the other cell lines (the
HeLa XRCC4 knockout sample had 83 genes, and the mirin-treated HeLa cells had 30 genes uniquely
differentially expressed). Pathways unique to the XRCC4 knockout+mirin group included differential
expression of p53 downstream pathways, and metabolic pathways indicating cell adaptation for energy
regulation and stress response. In conclusion, our study showed that TALEN-induced DSBs are repaired,
even when a key DSB repair protein or protein function is not operational, without a change in indel
profiles. However, transcriptional profiles indicate the induction of unique cellular responses dependent
upon the DNA repair protein(s) hampered.
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1. Introduction

published maps and institutional affil-

DNA carries genetic instructions for the development and function of all known living
organisms; therefore, it is important to preserve the integrity of the DNA. However, DNA
is not inert, but susceptible to multiple types of damage. The common sources of DNA
damage include environmental agents such as UV light, ionizing radiation, and chemical
mutagens. Additionally, endogenous biological processes such as cellular metabolism
including oxidative damage, DNA alkylation or hydrolysis, and double-strand breaks
(DSBs) from collapsed replication forks contribute to DNA damage. Every day, DNA
in normal cells has approximately 10–50 DSBs and thus requires efficient repair of DNA
damage to maintain its integrity [1]. Failure to repair such damage can lead to genomic
instability, cellular transformation, and cell death.
To mitigate DNA damage and maintain integrity, cells have multiple molecular mechanisms to repair different types of damage. The most deleterious DNA damage is arguably
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a DSB, which, if left unrepaired, threatens the loss of chromosomal content. The key machinery to repair DSBs are: (i) classical non-homologous end joining (referred to herein as
NHEJ) repair, and (ii) homologous recombination repair (HRR) [2]. Studies using chicken
DT40 cells deficient in NHEJ or HRR proteins established NHEJ as the predominant form
of repair in G1 phase, able to commence repair in any phase of the cell cycle, whereas HRR
was active only during late S or G2 phases of the cell cycle [3]. NHEJ is catalyzed by two
core protein-DNA complexes, Ku70/Ku80/DNA-PKcs and DNALig4/XRCC4/XLF [4].
The heterodimer Ku70/80 is first to recognize the DSB ends, allowing the DNA-dependent
protein kinase catalytic subunit (DNA-PKcs) to then load onto the ends acting as a scaffold
for the assembly of the remaining NHEJ factors [5]. In G1, a mammalian cell can repair the
majority of its DNA DSBs within ~30 min using NHEJ [2]. However, a biphasic repair of
DNA DSBs has been observed with a half-time for fast repair of between 7 and 14 min, and
the half-time of slow repair (~15% of breaks) between 60 and 90 min. The fast process is
not thought to require resection, whereas the slow repair process does [2]. Typically, NHEJ
attempts to repair DNA DSB first, but if a cell is in late S or G2 phases, it will be processed
by HRR at a later time following DNA damage [6,7]. One disadvantage of NHEJ is that it
is slightly more error prone and often introduces indels or scars [8], whereas HRR is less
error prone in comparison [9].
XRCC4 is a well-studied DNA repair protein known to stimulate the activity of
DNA ligase IV, catalyzing DNA end joining [10]. Schulte-Uentrop et al. demonstrated
that knockout of XRCC4, a component of the LIG4/XLF/XRCC4 complex, rendered cells
sensitive to DNA damage caused by either ionizing radiation or enzymatic cleavage of
genomic DNA such as the TALENs we use in this paper [11,12]. Targeted inhibition
of XRCC4, a component of the NHEJ ligation complex, should inhibit standard NHEJmediated DNA repair [8,9]. However, other backup repair pathways besides HRR do
not require XRCC4. For example, an alternative form of DSB repair called alternativeend joining (A-EJ) was identified from persistent end joining activity in cells deficient
for NHEJ [13]. A-EJ is evolutionarily conserved and can act in both NHEJ-proficient or
-deficient cells [14]. A-EJ can mediate repair by three different pathways [15]. Single-strand
annealing (SSA) requires an end resector of either MRN/CtIP/EXO1/DNA2, Rad52 as an
end bridger, and XPF-ERRC1 endonuclease for flap cleavage. Microhomology-dependent
DNA repair (MMEJ) requires one of the resectors listed in SSA as well as PARP, MRN or
polθ as an end bridging factor. Finally, end-joining (EJ) requires PARP, an end-bridger, and
ligase I as a ligating factor [16]. The A-EJ pathways are thought to be highly mutagenic,
with MMEJ using short sequence homologies near the two ends and often resulting in
small deletions [17]. In addition, the loss of XRCC4 expression increased the dependence
of repair on the MMEJ repair pathway [18].
MRE11 performs its functions as part of the MRN complex, consisting of three proteins:
meiotic recombination 11 protein (MRE11), RAD50, and Nijmegen breakage syndrome 1
(NBS1; also known as nibrin). MRE11 has two different nuclease activities: an endonuclease
activity that is essential to initiate DNA end resection, and a 50 to 30 exonuclease activity.
MRE11 was first noted to have a role in HRR, with subsequent work revealing additional
roles for MRE11 in NHEJ and A-EJ [19,20]. Its function in NHEJ and HRR is thought to
be mainly as a scaffold to help aid in DNA synapsis, whereas, its nuclease is key in its
role in A-EJ, specifically MMEJ repair [21]. Mirin (Z-5-(4-hydroxybenzylidene)-2-imino1,3-thiazolidin-4-one) inhibits Mre11-associated exonuclease activity, preventing MRNdependent activation of ATM without affecting ATM protein kinase activity, eliminating
the G2/M checkpoint and HRR in mammalian cells [22]. Depletion of MRE11 is associated
with the reduction in MMEJ repair in normal cells and inhibition of resection in HeLa
XRCC4 knockout cells, which further supports its role in A-EJ [19].
DSB repair has been extensively studied by damaging DNA in a GFP reporter harboring a I-Sce1 meganuclease cleavage site [23]. In the past decade, new gene-editing
approaches such as zinc finger nucleases (ZFNs), transcription factor-like effector nucleases
(TALENs), and clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9)
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have emerged and gained widespread applications in basic science, biotechnology, and
medicine. However, despite growing applications, far less is known about the repair
pathways and proteins functioning to repair damage induced by TALENs. TALENs bind
to DNA through a DNA binding domain consisting of an array of modular repeats with
each repeat binding a specific base in the DNA target. These TALEs are fused to the FokI
endonuclease catalyzing DSBs upon dimerization. Mosbach et al. showed that recombination proteins Rad52, SAE2, and MRE11-Rad50 complex are required for repair of DSB
induced by TALENs in yeast [24]. Our lab had previously used TALEN-based editing to
inactivate HIV proviral DNA [25], and have now adapted this system to study the repair
mechanism(s) that catalyze repair of TALEN-induced DSBs.
In this work, we constructed a TALEN-based reporter assay system that can detect
repair following TALEN-induced DSBs. Using this reporter construct, we show that repair
occurs even when both the XRCC4 protein and MRE11 exonuclease activity are inhibited
separately, or simultaneously. Furthermore, the transcriptional profiles of the HeLa XRCC4
knockout cells treated with mirin, a pharmacological inhibitor of MRE11 exonuclease
activity, had 307 uniquely differentially expressed genes, many more transcripts than either
the HeLa-NT (control), XRCC4 knockout HeLa or mirin-treated HeLa cells. The inhibition
of XRCC4 and MRE11 exonuclease activity was associated with differential expression of
p53 downstream pathways, and metabolic pathways suggesting adaptation of the cells to
target regulation of energy and stress upon DNA damage and inhibited repair.
2. Results
2.1. Construction and Validation of a DNA Repair Reporter Assay
To test and detect DNA repair following TALEN-induced DSBs, we first constructed
and tested a plasmid encoding an extrachromosomal reporter assay system. The reporter
plasmid has a CMV promoter for constitutive expression of the mCherry coding sequence.
The mCherry coding sequence is flanked on either side with TALEN binding sites [TBSs,
(Figure 1A)]. Under normal conditions, the mCherry reading frame terminates with a stop
codon. Consequently, the downstream GFP coding sequence lacks a promoter; and hence
is not expressed. When the cells are co-transfected with the reporter plasmid and the
pair of TALEN-expressing plasmids that target the encoded TBSs, DSBs are introduced at
both TBSs, thus excising the mCherry coding region. Upon subsequent repair, the CMV
promoter is ligated in proximity to the GFP coding region, driving its expression. Therefore,
GFP is expressed upon repair of the TALEN-induced DSBs. A flow chart depicting the
relationships between various DNA editing possibilities and fluorescence output is shown
(Figure 1A).
First, we tested the reporter assay system in HeLa cells. The reporter plasmid was
co-transfected with TALEN expression constructs T256 and T278, which recognize the 50
and 30 sequences, respectively. GFP positive (GFP+ ) cells were detected indicating editing
(Figure 1B). Co-transfection of the reporter plasmid with empty vectors, or with the 50 or 30
TALEN from the pair did not express any GFP+ cells as would be expected for cells that are
unedited or mono-edited (Figure 1B). This experiment confirms that our assay system is
functional, sensitive, detects DNA repair, and requires both the 5’ and 3’ TALENs.
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2.2. Inhibition of MRE11 Exonuclease Activity in an XRCC4-Deficient Background
To determine the effect of loss of XRCC4 and MRE11 exonuclease function on TALENinduced repair, we needed to abolish or inhibit this protein or protein function, respectively.
XRCC4 was knocked out in Hela cells using targeted CRISPR-Cas9 editing within the coding
region. The XRCC4 knockout in clone 2G3 was confirmed by the loss of XRCC4 protein
expression as detected by Western blot analysis (Figure 1C). A complete absence of XRCC4
protein expression was observed, and this clone was selected for further experiments. The
knockout in clone 2G3 was confirmed by Sanger sequencing and revealed a 2 bp deletion and
10 bp deletion in each allele, respectively, of the XRCC4 gene (Figure 1D). For knockout of
the MRE11 exonuclease function, we used mirin, which has been published to inhibit MRE11
exonuclease and other downstream activities at a concentration of 100 µM [22,26–30].
2.3. XRCC4-Deficient Cells Treated with Mirin Still Repair TALEN-Induced Breaks
TALENs have a high affinity (nM) for DNA, which could interfere with DNA repair [31]. We assessed whether TALENs impact DNA NHEJ repair activity. XRCC4 knockout and control cells HeLa-NT (non-targeting) transfected with reporter plasmid and
empty TALEN vectors did not show any GFP+ cells as expected for these negative controls
(Figure 2A,E). Mirin treatment of these cells also did not affect GFP expression
(Figure 2B,F). mCherry expression indicated that the cells were expressing the reporter
construct (Figure 2). Many HeLa-NT and XRCC4 knockout cells co-transfected with the
reporter and TALEN constructs (T270 and T278) showed GFP expression, indicating DSBs
followed by NHEJ repair (Figure 2C,G).
In co-transfected HeLa-NT cells treated with mirin, GFP+ cells were present indicating repair when MRE11 exonuclease activity is inhibited (Figure 2D). Surprisingly,
co-transfected mirin-treated XRCC4 knockout also showed repair as indicated by the presence of GFP expression (Figure 2H). This suggests that repair is sustained even when
XRCC4 is knocked out and MRE11 exonuclease activity are inhibited.
2.4. Repair Efficiency Is Lowered in XRCC4-Deficient Cells Treated with Mirin
To quantify repair efficiency, cells positive for the fluorescent reporters were quantified
by flow cytometry. Cells were first gated based on mCherry+ expression, selecting the
population expressing the reporter system. Next, we determined the percentage of cells
expressing GFP within the mCherry+ cell populations (Figure 3A,B). The mean percentage
of GFP+ expressing cells within the mCherry+ cells for each sample is compared in Figure 3B.
The relative efficiency of repair was (44.5% ± 1.0) in HeLa-NT cells and (30% ± 1.1) for
HeLa-NT cells treated with mirin, when compared to control HeLa-NT cells (Figure 3B),
indicating that blocking MRE11 exonuclease activity reduced repair efficiency. Similar
inhibition of repair was observed in XRCC4 knockout cells (31% ± 0.6) or those treated with
mirin (26.3% ± 0.9). These results indicated that repair was possible even with a knockout
of XRCC4 or mirin treatment (inhibition of MRE11 exonuclease), or both in combination.
The efficiency of repair as compared to control was reduced by ~30–40% in the various
knockout and/or inhibited cell lines.
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The reporter assay demonstrates that DNA DSB repair is partially inhibited, but still
The reporter assay demonstrates that DNA DSB repair is partially inhibited, but still
present
in XRCC4 knockout cells and/or cells treated with mirin. To assess the molecular
present in XRCC4 knockout cells and/or cells treated with mirin. To assess the molecular
basis for the remaining repair activity, transcriptomes were compared for cells with XRCC4
knockout plus and minus mirin treatment. mRNA from cells was sequenced by RNA-seq
and transcripts were identified. We harvested RNA 48 h post-transfection to give enough
time for the reporter and TALENs to be expressed, repair to occur or be blocked, and then
enough time for longer-term transcriptional changes beyond that of typical intermediate-
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The transcriptional changes are summarized in a Venn diagram to codify similar and
unique genes among samples. The XRCC4 knockout sample had 83 genes and mirin-treated
HeLa cells had 30 unique DEGs (Figure 5B). However, the mirin-treated XRCC4 knockout
cells had 307 uniquely DEGs, far greater than other samples reflecting a more impactful
transcriptional response. This differential transcriptional response was further supported
when the top DEGs were compared with a heatmap (Figure 5C and Table S2). The gene
expression for XRCC4 knockout cells treated with mirin was the most different from HeLa-
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The transcriptional changes are summarized in a Venn diagram to codify similar and
unique genes among samples. The XRCC4 knockout sample had 83 genes and mirintreated HeLa cells had 30 unique DEGs (Figure 5B). However, the mirin-treated XRCC4
knockout cells had 307 uniquely DEGs, far greater than other samples reflecting a more
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2.6. Pathway Analysis of Differentially Expressed Genes (DEGs)
We next sought to determine which pathways are functionally associated with the
transcriptional response to blocking major repair pathways. DEG enrichment was analyzed
with Metascape [33]. Meta-enrichment analysis indicated that all three conditions with
inhibited repair were consistently enriched in several pathways: transcriptional misregulation in cancer, alcoholism, defense response to viruses, and response to oxygen levels
(Figure 6A). Pathways unique to XRCC4 knockout cells with or without mirin were extracellular matrix organization, core matrisome, and endoderm and fat differentiation pathways
(Figure 6A). Pathways such as carboxylic acid biosynthetic process, p53 downstream pathways, and HIF signaling pathway were enriched in XRCC4 knockout + mirin group and
HeLa-NT treated with mirin but more pronounced in XRCC4 knockout + mirin group.
Interestingly, pathways unique to XRCC4 knockout with mirin group were regulation of
small metabolic processes, P53 regulates transcription of cell death gene, generation of
precursor metabolites and energy (Figure 6A). A network layout was created by enrichment
analysis and visualized with Cytoscape (v3.1.2) (Figure 6B). Such a network reveals the
interrelation of enriched pathways and genes.
2.7. Protein-Protein Interaction (PPI) Network Construction and Pathways Interaction Analysis
Pathways were also evaluated by examining protein–protein interaction networks.
A protein–protein interaction network was constructed from the DEGs for the 3 sample
conditions with BioGrid in Metascape [33]. The network contained a total of 237 nodes
and 956 edges where network nodes are displayed as pies (Figure 7A). Seven significant
network modules were identified with the MCODE algorithm (Figure 7B), which included
71 proteins from which ENO3, CACNG6, ITGB8, PDE10A, COL12A1, and FSTL3 served
as seed proteins. Gene Ontology (GO) terms associated with each module are depicted
in Figure 7B and HDAC deacetylates histones appear to be the prominent GO term. Of
relevance with the latter is that human histone acetylation and deacetylation have been
shown to regulate the NHEJ repair pathways [34].
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formed in the different repair defective cells were not significantly different between groups,
suggesting at least with this exogenous construct, other repair pathways can repair these
simpler breaks like controls.
We considered three plausible explanations for the persistence and similarity of indels
following DSB repair despite inhibiting XRCC4 and MRE11 exonuclease activity: (1) Involvement of some form of A-EJ repair, e.g., PolQ-dependent MMEJ repair [36] and (2) that
other genes could compensate for functional deficits in MRE11 or XRCC4. Although Xing
et al. identified PAXX, a new paralogue of XRCC4 [37], this gene was not differentially
expressed in our experiments; and (3) post-translational modifications of known DNA
repair proteins or new protein-protein interactions that can modulate repair pathways
would not be detected by the RNA-seq analysis. In addition, many DNA repair proteins
are constitutively expressed, and not inducible upon damage exposure, thus modification
of repair proteins, rather than extensive changes in transcript levels may be expected [38].
Considering the latter hypothesis, our DEG analysis identified multiple pathways
that were induced in each of the inhibited populations. The results suggest induction of a
substantial regulatory response that may produce signaling cross-talk between the repair
pathways. Although, NHEJ is the major repair pathway for DSB in differentiated cells;
the temporal recruitment of different factors and complexes are not completely elucidated.
There may likely be interactions between these DNA repair pathways, which previous
work suggests.
In support of the latter hypothesis, studies on cross-talk of NHEJ with base excision
repair (BER) and HDR with some common proteins were identified [39,40]. Xia et al. has
demonstrated that Polβ which plays a central role in BER, exhibits a higher degree of
spatial colocalization with Ku70, a component of NHEJ in the nucleus following DNA
damage caused by methyl methanesulfonate or etoposide [41]. In vitro binding assays also
support interaction between Polβ and Ku70. MRE11 has a critical role in DSB recognition
and ATM recruitment in HRR pathways [42]. Another protein, BRCA1, is known to
regulate the nuclease activity of MRE11. BRCA1 phosphorylation mediated by checkpoint
kinase 2 (CHK2) enhances NHEJ fidelity but can also deplete 53BP1 in the S/G2 phase
to favor HRR, suggesting that post-translation modification of BRCA1 regulates pathway
preference [39,40]. Thus, it is possible that NHEJ could have signaling interactions from
cross-talk that still allow repair [14,43].
We realize that the simple TALEN-induced DSB does not provide the same landscape
of breaks that would be observed in a normal context in genomic DNA following damage.
However, it was of interest to center on more uniform damage within a particular section
of DNA to discern if indel patterns differed, thus predicting the unique usage of a variant
repair pathway. However, between all groups of repair proficient and defective cells, there
was a similar pattern of insertions and deletions overall, with insertions in nearly all cases
just a single bp whereas the number of deleted nucleotides showed much more variability.
The single base pair insertion observed is likely due to terminal deoxynucleotidyl transferase (TdT), which typically adds a single nucleotide of microhomology, and thus does
not invoke the action of any polymerase in repairing this damage [44], whereas the wide
variety of deletions exhibited perhaps reflect the differing A-EJ pathways utilized, whose
repair may cause the elimination of various numbers of nucleotides depending on various
factors, such as microhomology. The prevalent 11 bp deletion, again observed in all the four
sample types, is also of interest. We expect that his unique type of edit is due to recursive
cleavage by TALENs and repair of the DSB. Cycles of cleavage and repair may eventually
produce a long enough deletion or insertion in the spacer region beyond which the Fok1
domains in the TALENs can no longer heterodimerize and cleave the DNA target region.
Although one might expect differences in the types and ratios of various indels between
repair defective and control, this may have been limited due to the uniform type of break
within an exogenous construct which has been previously noted to not show the same
patterns of repair pathway usage as compared to genomic DNA [45].
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One theme that emerged was that blocking NHEJ pathways by either XRCC4 knockout
or mirin treatment alone or in combination lead to pathways such as transcriptional misregulation in cancer, alcoholism, defense response to viruses, and response to oxygen
levels. The error-prone nature of NHEJ is a major cause of carcinogenesis and blocking
of these pathways in our experiments correlates with the transcriptional mis-regulation
associated with the cancer pathway. The introduction of DSB/viral DNA can activate DNA
repair pathway components, which are also activated in a defense response to viruses [46].
Similarly, oxidative stress induces DNA damage and can activate repair [47]. Enrichment
of these pathways highlights cellular adaptation in response to DNA damage.
In interpreting these pathways, one must consider that RNA-seq is very sensitive, and
mild changes in conditions for each sample such as DNA species during transfection could
produce transcriptional changes. However, although the lead pathways must be verified
by further investigation, the changes in the expression were generally repeatable among
replicates, which is one approach to reducing false positives. Furthermore, we observed
transcriptional differences for genes or pathways that would be expected or that make
sense. For example, many histones had changes in expression (Figure 5C), and the p53
DNA damage response pathway and defense to virus pathways were changed; the latter
can induce DSB during integration (Figure 6A). Furthermore, many genes were affected by
more than one condition (Figure 5B).
Although, we did not identify any major DNA repair proteins to be uniquely altered in
XRCC4 knockout and mirin-treated cells, different pathways were enriched. For example,
pathways associated with regulation of small-molecule metabolic processes, P53 regulates
transcription of cell death genes and generation of precursor metabolites and energy, all
suggesting a major role played by genes of metabolic pathways. The metabolic enzymes
are known to play non-canonical roles outside their established metabolic roles especially
in gene regulation, DNA damage response, and apoptosis [48]. Among the metabolic
pathways, genes belonging to glycolysis were more prevalent and were downregulated.
Induction of glycolysis contributes to the enhancement of NHEJ repair pathway and here
we show that XRCC4 knockout with mirin-treated cells had lower expression of glycolytic
genes, PGK1, ALDOC, PFKFB4, TPI1, ENO3, PFKP, ENO2, HK2, when compared to control
HeLa-NT cells [49]. However, whether there is a feedback loop mechanism between
glycolysis and DNA repair pathway and its potential role in TALEN-induced damage
repair will require further investigation.
Depletion of another DNA repair enzyme, DNA-PKcs is previously shown to cause
alteration in the metabolic pathway and P53 expression levels [50]. Enhanced p53 activity
is a critical cellular signal for DNA damage. Under normal conditions, p53 remains in
an inactivated state. However, in response to DNA damage, the p53 is activated and
drives transcription of factors involved in the apoptosis, cell cycle, DNA repair, and cellular
senescence [51,52]. Therefore, to compensate for defective XRCC4 and MRE11, our results
show that the metabolic and p53 pathways are altered as an adaption to cellular stress
introduced by DSB and in absence of efficient EJ repair systems. Previous work has also
noted that inhibition of DNA PKcs improved HRR, suggesting a completion between
pathways and that cells compensate and change the relative usage of repair pathways
dependent upon the inhibition of pathway choice [53,54].
While the previously discussed p53 response has a well-known connection with DNA
damage and repair, chromatin modifications may be required to give repair proteins access
to the DSB. One major DEG category supports a possible role for chromatin modification
as part of the regulator response to inhibiting repair. In support of this, a set of histones
genes were identified in the protein–protein interaction studies, and these genes are also
part of the alcoholism pathway that is highly enriched in the XRCC4 knockout cells treated
with mirin (Figure 7B). HDACs deacetylation histones have a major influence on chromatin
structure and regulate the activation of DNA repair proteins [55]. Several reports are
supporting the profiles of histone acetylation affecting NHEJ [56–59]. HDAC inhibitors
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impair DNA repair, suggesting that upregulation of HDAC deacetylation contributes to
DNA repair in mirin-treated XRCC4 knockout cells [60].
In summary, the protein–protein interaction network analysis results suggest interconnectivity between the transcriptional responses for XRCC4 knockout and mirin treatment
(Fig 7A). This is consistent with our hypothesis and prior evidence of cross-talk and competition between different DSB repair pathways. Due to the malleable nature of the repair
pathways and the overlap in protein function in the various pathways, it is difficult to
ascertain the exact pathway(s) activated; however, it is obvious, in the absence of XRCC4
and inhibition of MRE11, that repair of exogenous DNA is robust and alternative pathways
provide a similar spectrum of indels upon repair.
4. Materials and Methods
4.1. Repair Reporter Plasmid Construction
For construction of an EJ reporter plasmid, the sequence corresponding to a TALEN
binding site (Figure 1A) was PCR amplified from pLai.2 HIV proviral plasmid (NIH
AIDS Reagent Program #2532) and cloned upstream of the mCherry coding sequence into
the NheI and AgeI sites of the pmCherry-C1 plasmid (Takara #632524). For cloning a
TALEN binding site (TBS) downstream of the mCherry coding sequence, the TBS was
amplified, fused with GFP coding sequence by overlap-PCR and cloned between the SalI
and BamHI restriction enzyme sites. The coding sequence of EGFP was amplified from
the plasmid pEGFP-C3. A spacer was introduced between the cytomegalovirus promoter
(CMV) promoter and the upstream TBS at the NheI restriction enzyme site (New England
Biolabs Inc., Ipswich, MA, USA) within the pmCherry-C1. Primers used for sequencing
and cloning are listed in (Table S1).
4.2. Cell Culture and Lentivirus Production
HeLa (ARP 154) cells obtained from the NIH AIDS reagent program and LentiX293T
cells (Clonetech Laboratories, Mountain View, CA, USA; #632180) were grown in Dulbecco modified Eagle’s Medium (DMEM) supplemented with 10% FetalClone III Serum
(HyClone Laboratories, Logan, UT, USA; #SH30109.03). Lentivirus was produced from
transfected LentiX293T cells. Briefly, 6 well plates were seeded with 0.6 million cells
and incubated for 24 h prior to transfection. Cells were co-transfected with gXRCC4lenticrisprV2/gScrambled-lenticrisprV2, 1.2 µg; psPAX-2 (Addgene Watertown, MA, USA;
#12260), 1.0 µg, and pHEF-VSVG (Addgene #22501), 0.3 µg using the Lipofectamine LTX
transfection reagent (Invitrogen, Waltham, MA, USA) at a 1:3 ratio [DNA (µg): Transfection
reagent (µL)]. After 6 h of incubation, media was replaced, and cells were cultured in complete media for 48 h. Cell supernatant were collected, filtered through a 0.45 µm syringe
filter (MilliporeSigma, Burlington, MA, USA), and used for transduction into HeLa cells.
4.3. Assessment of DNA Editing
TALEN expression constructs (TAL 256 and TAL 278) were previously constructed with
the Joung Lab REAL Assembly TALEN kit (Addgene, Watertown, MA, USA) [25,61]. To
assess DNA repair, HeLa cells (0.6 million) were seeded a day before transient transfection,
co-transfected with a mCherry/GFP reporter plasmid and pairs of TALEN-expressing
constructs [TAL 256 (200 ng) and TAL 278 (200 ng)] at a ratio of 1:3 [DNA (µg): Transfection
reagent (µL)] with Viafect transfection reagent (Promega, Madison, WI, USA). As a control,
the reporter plasmid was co-transfected with empty vector [JDS70 (200 ng) and JDS 78 (200
ng)]. Medium was changed after 4 h incubation and replaced with complete medium with
or without mirin (Sigma Aldrich, St. Louis, MO, USA; 100 µM). After 48 h, cells were tested
for mCherry and GFP fluorescence by fluorescence microscopy and flow cytometry.
4.4. Generation of a XRCC4 Knockout Cell Line
To generate a XRCC4 knockout HeLa cell line, a gXRCC4 sequence targeting the XRCC4
gene (NCBI RefSeq:NC_000005.10) was annealed, phosphorylated with T4 Polynucleotide

Int. J. Mol. Sci. 2022, 23, 593

16 of 21

Kinase (New England Biolabs Inc., Ipswich, MA, USA) and cloned into the BsmBI digested
LenticrisprV2 plasmid (Addgene, Watertown, MA, USA; #52961)). The plasmid was
delivered into HeLa cells by lentiviral transduction. The cells were selected in complete
media with puromycin (1.5 µg/mL) for 1 week followed by clonal selection. Clonal cells
were screened for tri-allelic XRCC4 knockout by Western Blotting with a XRCC4 antibody
(Santa Cruz Biotechnology, Inc., Dallas, TX, USA; sc-271087) on Nitrocellulose membrane
(GE Amersham, Waukesha, WI, USA) and by targeted sequencing of gDNA. One of the
clones 2G3 (HeLa XRCC4 knockout cells) was selected for all subsequent experiments. For
the control HeLa cells, non-targeting guide RNA was similarly expressed in HeLa cells.
Genomic DNA (gDNA) was isolated from HeLa XRCC4 knockout and HeLa-NT (control
cell containing non-targeting gRNA) using Quick -DNA MiniPrep Plus Kit (Zymo Research,
Irvine, CA, USA). Isolated gDNA spanning the selected region of the XRCC4 gene (NCBI
RefSeq: NC_000005.10 (83104920-83105621) was amplified by PCR with XRCC4-SeqV2FP
and RA-XRCC4seq-RP primers and Herculase II Fusion DNA polymerase (Agilent, Santa
Clara, CA, USA). PCR amplified product was digested with XhoI (New England Biolabs,
Ipswich, MA, USA), and subcloned into the XhoI and EcoRV restriction enzyme sites of
the pBlueScript II SK (-) vector. Several colonies were screened for the XRCC4 gDNA
insert, and mutations in the XRCC4 region in the 2G3 clonal cells were confirmed by sanger
sequencing.
4.5. Fluorescence Microscopy
Transfected cells were cultured for 48 h before measuring fluorescence. Live cells
were assessed for EGFP and mCherry fluorescence in fresh media. Images were acquired
at 200× magnification with a Nikon TE2000E epifluorescence microscope equipped with
Photometrics CoolSNAP FX Camera (Roper Scientific, Sarasota, FL, USA). Images were
captured in sequential scanning mode to avoid spectral bleed through and were analyzed
in triplicate with multiple scanning regions for each.
4.6. Fluorescent Activated Cell Sorting (FACS)
Transfected cells were cultured for 48 h before flow cytometry analysis. Cells were
trypsinized, washed twice with phosphate buffered saline (PBS) and fixed with 2%
paraformaldehyde for 10 min at RT. Cells were washed twice with PBS before acquisition with a flow cytometer (Sony SH800, San Jose, CA, USA). Cells were gated first for
mCherry expression followed by GFP expression. Experiments were analyzed using FlowJo
10.7.1 for triplicate samples.
4.7. RNA-seq and Data Analysis
Cells were transfected with a mCherry/GFP reported plasmid and TALEN constructs
and treated with mirin or vehicle control after 4 h post-transfection. Cells were harvested
48 h after transfection and total RNA was extracted with the Quick-RNA Miniprep Plus Kit
(Zymo Research, Irvine, CA, USA). Duplicate samples for each condition were analyzed.
RNA was quantified, RNA-seq was performed at a depth of more than 20 million paired
end reads for each sample (Novogene, Cambridge, UK).
The RNA-seq data can be accessed at Gene Expression Omnibus (GEO) (accession no
GSE135274). For RNA-seq analysis, raw reads were imported into CLC Genomics Workbench 12.0 and trimmed using the quality limit score of 0.05 calculated from a modifiedMott trimming algorithm [62], read through adapter trimming, and trimming of ambiguous
bases from read regions with more than two ambiguous reads [62]. RNA-seq analysis was
performed with the RNA-seq Analysis tool in Genomics Workbench using default settings
including a mismatch cost of 2 with insertion and deletion cost of 3. The Reference genome
was hg19 and reference gene track used was ensemble_v74. Differential expression analysis
was performed in Genomics Workbench with the Identify and Annotate Differentially
Expressed Genes (DEGs) software.
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4.8. DNA Editing Indel Analysis
Cells were transfected as in Section 4.2. Post-48 h transfection, the plasmids from
the transfected cells are isolated using the Zyppy plasmid miniprep kit (Zymo Research,
Irvine, CA, USA). The region spanning the edited region within the plasmid was amplified
using the Herculase polymerase (Agilent, Santa Clara, CA, USA) with primers (TalIFP
NheI and mCherry Tal1RP). DNA libraries were prepared from the PCR amplified DNA
(100 ng) using NEBNext Ultra DNA Library prep kit for Illumina (New England Biolabs Inc.,
Ipswich, MA, USA) and the manufacturer’s protocol. Briefly, the DNA library preparation
involved multiple steps that include end repair and adaptor ligation. The size exclusion
selection and DNA clean-up after every step was performed using the 2× volume of
Ampure XP beads (Beckman Coulter, Brea, CA, USA). The DNA with ligated adaptors
DNA was further enriched by PCR (6 cycles) using the Universal PCR Primer/i5 primer
and Index Primer/i7 Primer of the NEBNext Muliplex Oligos for Illumina (New England
Biolabs Inc., Ipswich, MA, USA). Post-cleanup with 2X Ampure XP beads, the samples
were quantified and analyzed for size distribution using Agilent bioanalyzer 2100 (Agilent).
The DNA library was denatured and mixed with 20% denatured ΦX174. The samples were
sequenced in NextSeq500 (Illumina, San Diego, CA, USA). DNA-seq was performed at a
depth of more than 1 million paired end reads for each sample (Novogene, Cambridge,
UK). Reads were aligned and the length and frequencies of Indels were quantified.
4.9. Bioinformatic Analysis
A principal component analysis (PCA) of RNA-seq data and resulting plot were created with ClustVis accessed on 24 February 2021 [32]. Venn Diagrams of differentially
expressed genes for each condition was compared to control (FDR < 0.01 log FC >= 1) and
plotted with an online tool (http://bioinformatics.psb.ugent.be/webtools/Venn/ accessed
on 13 January 2021. Heatmaps for the DEGs were plotted using the Heatmap.2 function
in the R ggplot package R [63]. Volcano plots for each category were created using “EnhancedVolcano” function in R [64]. Gene enrichment analysis was performed for DEGs
lists (FDR < 0.01 and logFC > 1.2) with Metascape [33]. A network graph was created with
Cytoscape (v3.1.2). Term relationships having a similarity score above 0.3 are connected by
edges. The network is visualized with Cytoscape (v3.1.2).
For indel analysis, raw reads were trimmed for capturing TALEN editing inserts/amplicons
and removing TALEN binding primer sequences (50 -primer: GAAGAAGCGTAAGGTCTAGC
and 30 -primer: TAACTAGGGAACCCACTGCT) using Cutadapt [65]. Read 1 and read 2
from pairs were processed independently as technical replicates, as it was unnecessary
to consider multiple alignments here. Trimmed reads with TALEN editing inserts were
aligned to the reference sequence (GAGCCTGGGAGCTCTCTGGC) using BWA-MEM [66].
Nucleotide substitutions, insertions and deletions introduced by TALEN editing were
identified/called as variants (SNVs and Indels) using SAMtools/BCFtools mpileup [67]
and summarized using modified parameters (–max-dept ReadCount) to break through
maximum read depth (default: 250). Finally, called variants (.vcf file) from each sample
were summarized using a Perl script and imported into an Excel file for comparison of
indel lengths.
4.10. Protein–Protein Interaction (PPI) Network Analysis and Pathway Interrelation Analysis
PPI networks were constructed using multiple DEGs list based on BioGrid, InWeb_IN
and OmniPath database in Metascape. For networks which contain between 3 and 500
proteins, Molecular Complex Detection (MCODE) algorithm was used to identify densely
connected network components with default parameters. For each MCODE component,
pathway and process enrichment analysis was applied and the three best-scoring (by
p value) terms were retained as the functional description of the resulting modules. Resulting network graphs were visualized through Cytoscape (v3.1.2).
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4.11. Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)
For validation of RNA-seq results, cells were transfected with a mCherry/GFP EJ
reporter plasmid, TALEN expression constructs, and treated with mirin or vehicle control
as described above. Cells were harvested 48 h after transfection, Total RNA was extracted
using the Quick-RNA Miniprep Plus Kit (Zymo Research, Irvine, CA, USA) and cDNA
was synthesized with SuperScript™ IV VILO™ Master Mix (Invitrogen-Thermo Fischer
Scientific, Waltham, MA, USA). Gene expression of select DEGs were quantified by qRTPCR with gene-specific primers (Table S1), and PowerUp SYBR Green PCRmix (InvitrogenThermo Fischer Scientific) in a Bio-Rad CFX96 Touch™ Real-Time PCR Detection System.
Relative expression levels were normalized to a housekeeping control gene, β-actin. The
fold changes in mRNA levels between the HeLa-NT and the experimental condition were
calculated using the 2−(∆∆CT) method.
4.12. Statistical Analysis
Statistical analyses were conducted with Student’s t-test or by ANOVA for comparing
more than 2 groups and a p-value ≤ 0.05 was considered significant.
5. Conclusions
In conclusion, our results demonstrate that repair of TALEN-induced DS breaks is
robust even when two key DNA repair proteins involved in the major DSB pathways are
blocked or inhibited. The majority of repair activity was preserved with a corresponding
transcriptional response. In the absence of both XRCC4 and inhibition of MRE11, new
transcriptional responses likely associated with sub-pathways of A-EJ are evident.
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